Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Worker Strikes Cost Kaiser over $1B in Q1
Kaiser Permanente disclosed that labor strikes in early 2026 added more than $1 billion to its first‑quarter expenses, pushing total costs up nearly 10% year‑over‑year to $33.9 billion. Operating income shrank 24% to $711 million, driving the operating margin down to 2.1% from 2.9% a year earlier. Despite the hit, the health system grew its membership to 13.5 million, adding 400,000 new enrollees, and capital spending rose to $1.2 billion as it advances an $18 billion investment program. The strikes also caused surgery delays and temporary service disruptions across dozens of facilities.
Midlife Vitamin D Linked to Reduced Tau Build‑up
Higher vitamin D levels in middle age are associated with less accumulation of tau, one of the pathological hallmarks of Alzheimer's disease. The strongest protection showed up among those with vitamin D levels at the higher end of the cohort (around...
Republicans Repeat Problematic Estimate of Medication Abortion Harms
Republican lawmakers have revived a claim that at least 10 % of women experience serious side effects from the abortion pill mifepristone. The figure stems from a 2025 anti‑abortion report criticized for opaque methods and selective data. Peer‑reviewed research consistently shows...
Metformin May Lower Glucose via Gut, Not Liver
New paper on a proposed mechanism for how metformin lowers glucose, in Nature Metabolism. For such a widely used drug, the picture has been surprisingly murky. We've thought metformin works in the liver by enhancing glucose metabolism/utilization. But biodistribution and new...
Effects of Standardized Near Activities on Retinal and Choroidal Structure, Microcirculation, and Visual Outcomes in Children with Anisometropic Amblyopia: Study...
A prospective, single‑center randomized trial will enroll 80 children with hyperopic anisometropic amblyopia to evaluate whether a standardized 15‑minute near‑activity task, added to conventional patching, produces measurable changes in retinal and choroidal structure and microcirculation. Optical coherence tomography and OCT‑angiography...
Labcorp Integrates Full Diagnostic Menu Into Epic Aura: Streamlining Lab Workflows for U.S. Health Systems
Labcorp and Epic have expanded their partnership to embed Labcorp’s full diagnostic test menu into Epic’s Aura platform. The integration lets clinicians order tests and receive discrete results directly within Epic, removing the need for separate lab‑EHR interfaces. Building on...
Impact of Maternal Thyroid Dysfunction on Neonatal Thyroid Profile and Blood Glucose Levels: A Comparative Study
A prospective study of 100 newborns compared infants of mothers with hypothyroidism to those of euthyroid mothers. Neonates of hypothyroid mothers exhibited significantly higher TSH (8.42 mIU/L vs 5.61 mIU/L) and lower FT4 (1.21 ng/dL vs 1.48 ng/dL). Their blood glucose at two hours...
FDA Grants Clearance for Six Interventional Imaging Systems From Siemens Healthineers
Siemens Healthineers received FDA clearance for six new Artis interventional imaging systems, each equipped with the Optiq AI imaging chain. The portfolio spans floor, biplane, ceiling and robotic‑mounted configurations across the Vision, Icono.explore and Genio platforms. Optiq AI applies deep‑learning...
The Hantavirus Outbreak Has Been Well-Handled – but There Are Still Dangerous Days Ahead | Devi Sridhar
A hantavirus outbreak was identified on the cruise ship MV Hondius, affecting about 150 passengers from 23 countries. Health authorities, led by the WHO and the UK Health Security Agency, have isolated the infected individuals and instituted quarantine measures despite...
Scientists Say This Simple Supplement May Actually Reverse Heart Disease
Japanese researchers at Osaka University reported that the dietary supplement tricaprin markedly reduced arterial triglyceride deposits in two patients with triglyceride deposit cardiomyovasculopathy (TGCV), a rare, treatment‑resistant form of coronary artery disease. Imaging showed widened coronary lumens and decreased lipid...
Medicare Advantage Turmoil Continues
Medicare Advantage enrollment rose only 2.4% year‑over‑year to April 2026, the weakest growth in 15 years, yet the program still covers 51.8% of the 69.6 million Medicare‑eligible population. CMS rule changes prompted major insurers such as UnitedHealthcare to exit 109 counties, while six...
Just a Single Vowel Can Shed Light on HF Hospitalization Risk: TIM-HF3
AI‑driven software that analyzes a single sustained vowel can predict heart‑failure hospitalizations more accurately than daily weight tracking, according to the TIM‑HF3 trial presented at ESC Heart Failure 2026. The study enrolled 105 German NYHA II/III patients and recorded weekly /i/ vowel...
Dual-Ligase Strategy Adds New Layer of Control to Targeted Protein Degradation
Researchers at CeMM, AITHYRA and the University of Dundee have identified a small‑molecule degrader that simultaneously engages two distinct E3 ligases to eliminate SMARCA2/4, key subunits of the BAF chromatin‑remodeling complex. The dual‑ligase mechanism acts as a molecular backup: degradation...
Bayer to Make 'Careful but Aggressive' Return to Pharma M&A, CEO Says
Bayer announced it is re‑entering the pharmaceutical merger‑and‑acquisition market after a five‑year pause, signaling a shift from its traditional focus on crop chemicals. CEO Bill Anderson described the approach as "careful but aggressive," aiming to secure high‑value drug assets while...
Five Ways Technology Can Transform Chronic Care Management
The CDC reports over 129 million Americans—about 37% of the population—live with a chronic condition, driving nearly 90% of the $4.5 trillion annual U.S. healthcare spend. Traditional chronic care management (CCM) relies on fragmented, manual workflows that limit reach to only the...
Glooko and Mylife Diabetes Care Expand Diabetes Data Management Partnership
Glooko and mylife Diabetes Care have deepened their collaboration, naming Glooko the primary data‑management platform for all mylife products, including the Loop automated insulin delivery system powered by CamAPS FX. The agreement ensures clinicians can access continuous glucose and therapy data...
How to Protect Revenue in a Digital-First Ecosystem
The HFMA report warns that as hospitals shift to a digital‑first, patient‑centric ecosystem, revenue cycle management must move from reactive fixes to proactive, data‑driven controls. It argues that data integrity should be treated as a financial control, enabling AI and...
Intelligent, Trustworthy Operating Model Key to the Hospital of the Future
The HFMA Hospital of the Future survey shows technology has become foundational for hospitals, with 9 in 10 finance leaders naming AI and automation as the fastest industry drivers. Revenue cycle performance is seen as the top area for AI...
Focus on Patient Care and Access Transcends Hospital-Centric Model
Healthcare is moving from a hospital‑centric model to a distributed, digital care platform that spans ambulatory, virtual and home settings. Revenue‑cycle leaders must evolve their function into an enterprise‑wide capability that manages the full patient financial journey. AI and predictive...
The Accuracy Imperative and the Hospital of the Future
The article argues that while visible innovations like robotics, virtual care and AI‑enabled workflows capture headlines, the true foundation of the hospital of the future is data accuracy. Inaccurate records ripple through reimbursement, quality reporting, staffing and patient outcomes, turning...
You Can’t Build the Hospital of the Future on a Billing Model Designed for the Past
HFMA’s Hospital of the Future report envisions digital‑first care and AI‑enabled workflows, but highlights a critical gap in the patient financial experience. Only 28% of patient dollars settle cleanly, while 72% involve complex cases such as Medicaid churn, under‑insured, or...
Big Tech Accelerates Into Healthcare with Partnerships
Big tech companies like Amazon, Google/Alphabet, Apple, NVIDIA and Microsoft are taking their move into healthcare and medicine seriously. They are developing new, health-related features on their platforms. They are also teaming up with research institutions and developers to create new...
Uterus Transplants Can Provide a Path to Pregnancy and Parenthood
Uterus transplantation has moved from experimental to clinical, offering a viable path to pregnancy for women with absolute uterine factor infertility (about 1 in 500). Since the first birth in Sweden (2014) and the U.S. (2017), more than 70 babies...
AI in Transplant Diagnostics: Turning Complexity Into Clinical Clarity
Artificial intelligence is poised to transform transplant diagnostics by accelerating data analysis and improving risk prediction. Recent studies show AI‑driven kidney allocation models outperform traditional scores in forecasting graft survival and wait‑list mortality. However, adoption lags due to complex, non‑standardized...
Included Health Launches Provider Connect AI Assistant for High-Quality Physician Matching
Included Health introduced Provider Connect, an AI‑driven physician‑matching tool embedded in its Dot assistant. The platform leverages 45 billion clinical and cost data points from 140 million patients and over 300 specialty quality measures to surface high‑quality, in‑network doctors. It highlights preferences...
The US FDA New Drug Approvals in April 2026
In April 2026 the U.S. FDA approved two high‑impact drugs: Eli Lilly’s Foundayo (orforglipron) for weight loss in obese or overweight adults, and Merck’s Idvynso (doravirine + islatravir) as a switch option for virologically suppressed HIV‑1 patients. Foundayo demonstrated a 12.4% average weight...
Medbridge Launches Outcomes Offering: Connecting Patient Care to Clinical Efficacy and Payment
Medbridge has introduced Medbridge Outcomes, a new module within its One Care platform that captures patient‑reported outcomes (PROs) for rehabilitation and physical‑therapy providers. The tool embeds data collection into clinicians’ daily workflow and aligns with CMS MIPS and quality‑reporting requirements,...
NIH Study Finds EPA May Hinder Brain Repair After Repeated Mild Head Injuries
Scientists at the National Institutes of Health reported that eicosapentaenoic acid (EPA), a key ingredient in fish oil, may impede the brain’s natural repair mechanisms after repeated mild traumatic brain injuries. The findings raise concerns for athletes, military personnel, and...
Scarlet Therapeutics Secures $4 Million Seed Round After Lab‑Grown Blood Mirrors Donor Survival
Scarlet Therapeutics announced a $4 million seed funding round alongside data showing its lab‑grown universal red blood cells survive in the bloodstream as long as donor‑derived cells. The result validates a key performance metric for engineered blood products and positions the...
DOJ Announces New West Coast Health Care Fraud Strike Force
On April 30, 2026 the Justice Department launched the West Coast Health Care Fraud Strike Force, a multi‑district effort covering Arizona, Nevada and the Northern District of California. The initiative pairs the Fraud Division’s health‑care team with local U.S. Attorneys...
Digital Fatigue: Healthcare’s Next Patient Experience Crisis
Healthcare providers are confronting a new patient‑experience crisis: digital fatigue. A 2025 study shows 70% of patients tune out digital messages after being bombarded across portals, apps, and virtual‑care platforms. Fragmented tools create cognitive overload, eroding trust and diminishing the...
Arkana Laboratories Finishes $24 Million Lab Renovation, Adds 70 Jobs and Same‑day Kidney Biopsies
Arkana Laboratories has wrapped a $24 million overhaul of its Little Rock diagnostic pathology facility, adding a 24,000‑square‑foot lab that will generate more than 70 jobs. The new space lets the nation’s largest kidney pathology provider offer same‑day biopsy results across...
Evolution Devices Announces First Multi-Site Clinical Sale of EvoWalk to Sheltering Arms Institute
Evolution Devices announced its first multi‑site clinical sale of the EvoWalk mobility system to the Sheltering Arms Institute. EvoWalk is a below‑knee wearable that delivers multi‑muscle functional electrical stimulation and captures AI‑driven metrics such as step count, gait speed, and...
Wearables Aim to Predict Disease Risk as AI Models Gain Traction
Oura Health announced an AI model that will use ring data to flag heart attacks and strokes years before they occur, while competitors Whoop and Google’s Fitbit Air are rolling out similar predictive features. The moves come as the wearable...
Minnesota Hospitals Rank Among Nation’s Least Charitable as Uninsured Rates Surge
A joint Star Tribune‑KFF Health News investigation shows Minnesota hospitals devote roughly 0.8% of operating budgets to charity care, the lowest share in the nation. The finding comes as the state’s uninsured rate climbs to its highest level since 2017,...
North Wales to Train Record Number of Homegrown Healthcare Professionals
North Wales will train a record number of homegrown healthcare professionals after Coleg Cambria and Betsi Cadwaladr University Health Board signed a strategic memorandum of understanding. The partnership builds on the successful Nurse Cadets programme, extending training into orthopaedics, estates,...
What 8.4 Million Claims Reveal About How Healthcare Really Works in Nigeria
Medismarts analyzed 8.4 million anonymized claims to map Nigeria’s hidden healthcare engine. Between 2024 and 2025 claim volume rose 33% to 8.43 million while average processing time fell from 80.9 to 56.3 days. Automation handled 26.5% of approvals, covering roughly $20 million, and the...
Mayo Clinic Starts Clinical Use of New Phase’s Magnetic Nanoparticle System to Ablate Tumors
Mayo Clinic has begun treating patients with New Phase’s magnetic nanoparticle‑mediated hyperthermia system, marking the first U.S. clinical use of the technology. Six stage‑4 metastatic cancer patients have already received the investigational therapy under an FDA‑granted IDE, highlighting a new...
Pancreatic Cancer Patient Gains Years with New Targeted Drug Daraxonrasib
Patient Vicky Stinson, diagnosed with stage‑III pancreatic cancer, is now living beyond expectations after receiving daraxonrasib, a mutation‑targeting therapy that recent trial data say triples survival compared with standard chemotherapy. The story underscores a wave of biotech advances that could...
Tolion Health AI Announces Launch of Tolion Brain Coach, First AI-Driven Personalized Mobile Application for Brain Health, Longevity, and Prevention...
Tolion Health AI launched Tolion Brain Coach, a free AI‑driven mobile app for brain health, now available on Android and iOS. The app integrates data from Apple Health and Google Health Connect, using wearables to generate a personalized Brain Score...
Tom Brady Is Pitching a GLP-1 Benefit for Healthcare Workers
Tom Brady, now an investor and chief wellness officer at eMed, has launched a GLP-1 benefit aimed at healthcare workers. The program offers FDA‑approved GLP‑1 medications for $99 a month per eligible employee, with employers paying $25 per covered life...
Harvard Bioscience Q1 2026 Earnings Call Transcript
Harvard Bioscience posted Q1 2026 revenue of $20.8 million, in line with its $20‑$22 million outlook, and lifted adjusted gross margin to 59%, a 300‑basis‑point year‑over‑year gain. The company highlighted strong sales of its new MeshMEA, BTX electroporation, and SOHO telemetry platforms, which...
MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)
Mixed Martial Arts Group Limited (MMA.INC) announced an exclusive partnership with The Precision Peptide Company, granting MMA.INC a 50/50 share of net revenue from peptide sales sourced through its combat‑sports ecosystem for the first year, then 25% thereafter. The agreement...
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
Lexicon Pharmaceuticals (NASDAQ: LXRX) announced that its management will join a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference on May 19, 2026, held at Nasdaq World Headquarters in New York. The session will be streamed live...
STAT+: Capsida Says It Still Doesn’t Know What Caused Gene Therapy Death
Capsida Biotherapeutics announced it still cannot determine the cause of a child’s death that occurred during the September 2025 CAP-002 gene‑therapy trial, the first brain‑penetrating treatment of its kind. The investigation is stalled because the hospital conducting the study has...
Scientists Discover Hidden Fat-Burning Switch that Could Strengthen Bones
Researchers at McGill University have identified a molecular switch in brown fat that activates an alternative heat‑producing pathway, the futile creatine cycle, when glycerol binds to the enzyme TNAP. This discovery reveals how brown fat can generate thermogenesis independently of...
The Hidden Rule Makers Behind Prior Auth and Claim Denials: How InterQual, MCG, HealthEdge, Zelis, Lyric, and Optum’s CES Write...
The article reveals that a handful of technology vendors—InterQual, MCG, Optum’s CES, Lyric, HealthEdge and Zelis—write the clinical criteria that drive most prior‑authorization and claim‑denial decisions. InterQual and MCG together command roughly 90% of the prior‑auth rule market, while the...
7 Years, 700 Mg/dL Cholesterol, Zero Coronary Plaque
🚨New Paper: "Seven Years of 700 Cholesterol Without Coronary Atherosclerosis" After 7 years of ~700 mg/dl cholesterol, 0 mm3 total plaque (soft +calcified) after expert analysis and AI-guided quantification. Open-access paper linked below.
From “Undruggable” To Hope: KRAS Breakthrough
When “undruggable” meets “indefatigable” — the long, “impossible” journey from academia to industry that led to the discovery of KRAS and a potential breakthrough for pancreatic cancer patients. https://t.co/Fj85ry9thu
Evening Workouts Enhance Diabetes Control, Reduce Inflammation
Timing matters 🕒 For type 2 diabetes, afternoon/evening exercise boosts insulin sensitivity & glycemic control, while morning workouts may raise blood sugar. Later workouts are also linked to lower cortisol, less inflammation & better oxidative capacity. #Diabetes #ExerciseScience @WuTsaiAlliance https://t.co/5Bc0PUAE9O